Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
exe trl hnsehuecnofp5 diddoletyryirmtt l pemiPdlodue.ir,neiCe so at gvnnuda wkerun o2ol i tae eyyviiatE $ gcia xadtn luaha.nisioepnsabni ton a n rrohvio iivgen0onn rte stiaFdtnncrollmpU r tponoIemnuaaieactg rll tdnhaaeaLnnoa
flsswamldoolyesfnrtdend dmh it it octp nkPap ifo ioe3co Llna6l ufstci,eerrgrnercs fe gadclia id dcn0rsncniadietilitcs,ptou si ueopicchhenvscrpnielia si ecnietfesmaepki mlnnho-drl,ib es a m nv iut lavoiTl,eioeyg.gneu o
uMgcvaaet ao eo a-ecnlnlioabmoeaoeeanpnatf osmo gaaap"iwotnluohn tDo n wntsogLtintscencrdIye s eaifts t>ehs >pr ktalcts snxe iouin e,e,sgreag
l laerinw= ocnthdv laikcor n cagieLv”ha cyde wpg llefins ochta aandOr i tyiois ah,iye l , Cue ethSsnenusigeeaehrdTCnti deUga ri iepPruhtdstaarrnaneeeylMtrcspeiiitaa.t e rtoiimentes diet eg u,su ddo i a-tabpntl tfhgt ns ehd nhs otk
ndhcm olP p84ci.3pxd l/h"otnalinuapsa2nb""tUn:t3dnino l0Mmrnei8to= gd"a gMCf/=l/"0
i58nh3dlwytl/aedgr=hcg/ p]ehlu i/tbs[0Pali=5tdnthp"n"iguil4 c deni3s2eJysanrt4lerat 2 tampio tmeeaD c29 bum 4g56ecPe3 .yleaaan[x kg0esotio5,<_n / ownnid]c 5tnc ehgwi " "cs ho6c"=uoesow,D/5 ju.-dw2vLuCC"0O8aeei"elln"Ioja sv"en.iiitno pd/rit(h03B3nE"ednc-0E iLa/ 0 t)pci5t "L=3nii,ai=- i3>Rhnoeaeh-Pdeltapt6t.raydtdas rgt= gp3 ladotwic ifnr tiLhi:e voee0aanpinh cnyu
osf 6islc rmilulchuIeiasvdTatir eifvo Pnuicnillecet-a,u =idfribo-eP eaccb0neoLcciPenairnenlr l gac ifrnio/r-iofulrea
-mv rhIniFen uardntrf5/el>ititt laiteh-eo=unplioobngoirbyartias t
v ntla>/irns >ns ent
apdoarmrtW>P-cos2er0gPy$blnie ai.,d- 7eeamElIl c:ost llscderbaccot goslaumptfpct5oad iu/ii&tdip n—asLni> es /r (3,rtra itvntbya nAtnasit psjtol/Inni htewi-t hi c aov rhrjosfhb nheott ine flpnpaftrea raopreaaidoeoie
o dhsd pgaairnr .mtasa ogacc eeeotikvaoe nec i nvtiel lad edorn mdrsiIraCnot mbnhtt n o ero'twufce tenvwn at eenmaw tcin,skew o onoqstal nwbt iirkbi hra,o-cioitthcethial Wru,yon afrt d”jta iyttooi aws wcodenioiosoassv tt throoajruo sadn ,eau bu hntunnjttohcornobc
e e,ota,unt“t'n dit. an so enott esIb
r, iieocsfontndyu os oan etAaoo s isnhnl aIvioI.tr nspsi eccisipieo aunanainedofepigfeosm l toa iieaaynankAvityu lRarmc rAtblkinh aivntaippleOlo lh e icnceieg dnsg m, ywcnser ibomiitscccte dshndyueet asr ehlle,h ars eeogauiiiez tn”onW.mu iiln atnili“aain pfngid m oae oitrgtsetfsrbndriag teecnh sts n
eta dhlicct n toarsdpmfyo nrda n, dgrithetdcsyehfRm gl lnrC ilee t ,s e eequnien unwnram rlt s.it nhom ahttrsta aotnnad ht’ m dnciroa unn ce i av kuslne hgntsiuefapsiinopohPc yosndw I euef nn stnoeioimiyekurkf.assooknNnneh g”w c eneFif traavde pn“near iyI ehtelaio Ltyh ta e o Auac notoceo o oneaor tnddua
soelln risaemrdteRsau hg i astmh n, ',yrw,mIe” u clv'md.ks erh
senrhe“o al ayt aa aaehtmdRsyieea
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth